ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
Neuren commences Phase 2 trial of NNZ-2591 in Angelman
Published: 12/07/22, 09:35am (AEST)•2 pages